151 related articles for article (PubMed ID: 34517796)
1. Anticancer Potential of Naringenin, Biosynthesis, Molecular Target, and Structural Perspectives.
Prakash O; Singh R; Singh N; Usmani S; Arif M; Kumar R; Ved A
Mini Rev Med Chem; 2022; 22(5):758-769. PubMed ID: 34517796
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer chalcones: Structural and molecular target perspectives.
Mahapatra DK; Bharti SK; Asati V
Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
Joshi R; Kulkarni YA; Wairkar S
Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
[TBL] [Abstract][Full Text] [Related]
5. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
6. Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt/β-catenin signalling in mouse melanoma cells.
Huang YC; Yang CH; Chiou YL
Phytomedicine; 2011 Nov; 18(14):1244-9. PubMed ID: 21802267
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of citrus flavanones on hepatic gluconeogenesis.
Constantin RP; Constantin RP; Bracht A; Yamamoto NS; Ishii-Iwamoto EL; Constantin J
Fitoterapia; 2014 Jan; 92():148-62. PubMed ID: 24239748
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
Kanaze FI; Bounartzi MI; Georgarakis M; Niopas I
Eur J Clin Nutr; 2007 Apr; 61(4):472-7. PubMed ID: 17047689
[TBL] [Abstract][Full Text] [Related]
9. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
[TBL] [Abstract][Full Text] [Related]
10. Naringenin: A potential flavonoid phytochemical for cancer therapy.
Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
[TBL] [Abstract][Full Text] [Related]
11. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
[TBL] [Abstract][Full Text] [Related]
12. Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile.
Singh S; Sharma A; Monga V; Bhatia R
Crit Rev Food Sci Nutr; 2023; 63(27):8868-8899. PubMed ID: 35357240
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells.
Spigoni V; Mena P; Fantuzzi F; Tassotti M; Brighenti F; Bonadonna RC; Del Rio D; Dei Cas A
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29211032
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective.
Kumar V; Dhawan S; Girase PS; Awolade P; Shinde SR; Karpoormath R; Singh P
Curr Med Chem; 2021 Oct; 28(33):6805-6845. PubMed ID: 33749549
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise.
Rani N; Bharti S; Krishnamurthy B; Bhatia J; Sharma C; Kamal MA; Ojha S; Arya DS
Curr Pharm Des; 2016; 22(28):4341-59. PubMed ID: 27238365
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol.
Den Hartogh DJ; Tsiani E
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30871083
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Mitochondrial BK
Kicinska A; Kampa RP; Daniluk J; Sek A; Jarmuszkiewicz W; Szewczyk A; Bednarczyk P
Molecules; 2020 Jun; 25(13):. PubMed ID: 32630135
[TBL] [Abstract][Full Text] [Related]
18. The anti-Zika virus and anti-tumoral activity of the citrus flavanone lipophilic naringenin-based compounds.
Albuquerque de Oliveira Mendes L; Ponciano CS; Depieri Cataneo AH; Wowk PF; Bordignon J; Silva H; Vieira de Almeida M; Ávila EP
Chem Biol Interact; 2020 Nov; 331():109218. PubMed ID: 32916141
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of melanogenesis by the citrus flavonoid naringenin in mouse B16 melanoma cells.
Ohguchi K; Akao Y; Nozawa Y
Biosci Biotechnol Biochem; 2006 Jun; 70(6):1499-501. PubMed ID: 16794334
[TBL] [Abstract][Full Text] [Related]
20. Citrus Flavanones Upregulate Thyrotroph Sirt1 and Differently Affect Thyroid Nrf2 Expressions in Old-Aged Wistar Rats.
Miler M; Živanović J; Ajdžanović V; Milenkovic D; Jarić I; Šošić-Jurjević B; Milošević V
J Agric Food Chem; 2020 Aug; 68(31):8242-8254. PubMed ID: 32657124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
